|
|
||||||||
Indena Offers Patented Soyselect® Soy Isoflavones To Vitamin Manufacturers
Supported by two human clinical trials and featuring two standardized active constituents responsible for its efficacy - Indena, U.S.A.
February 28, 2005 Seattle, WA – Indena U.S.A. announced today that its soy isoflavone product SoySelect® is now available to vitamin manufacturers (go to the news)
Reduction of menopausal symptoms without use of oestrogens: the efficiency of a particular soy extract is scientifically demonstated
Milan, August 1st 2002 - The Italian company, Indena, which researches and produces active plant principles and extracts, has undertaken pharmaco toxicological and clinical studies to explore the
effectiveness of its soy extract, Soyselect® (go to the news)
Clinical effects of SOYSELECT® on postmenopausal women
Milan, June 1st 2002 - Epidemiological and clinical data suggest soy derivatives could provide a promising treatment of menopause-related symptoms in postmenopausal women. The results available however are often conflicting. This is largely due to the high variability in composition of the different soybean products tested. To minimise this potential source of bias, a standardised soy extract (SOYSELECT®), prepared by Indena was extensively investigated in several in vitro and in vivo models (go to the news)
